PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Xialin Chen

Shaoxing University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

Tislelizumab plus chemotherapy followed by anlotinib maintenance therapy in a patient with extensive-stage small cell lung cancer and intracranial recurrence after palliative whole-brain radiotherapy: a case report and literature review

Frontiers in Immunology

A single case report with a favorable outcome raises a mechanistic question about drug combination efficacy but provides no comparative evidence, control group, or generalizable data to support clinical practice change.

Hypothesis-GeneratingLung Cancer Research Studies Rong Ji Lung Cancer Treatments and Mutations

Reported

Overall survival67 months

Time to brain metastases after th…19 months

Time to intracranial recurrence a…5 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support